Elavil and Bronchial secretion retention - a phase IV clinical study of FDA data

Summary:

Bronchial secretion retention is reported as a side effect among people who take Elavil (amitriptyline hydrochloride), especially for people who are male, 60+ old, also take Flexeril, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Bronchial secretion retention when taking Elavil. It is created by eHealthMe based on reports of 19,133 people who have side effects when taking Elavil from the FDA, and is updated regularly.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

What is Bronchial secretion retention?

Bronchial secretion retention is found to be associated with 276 drugs and 309 conditions by eHealthMe. Check the latest studies of Bronchial secretion retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

19,133 people reported to have side effects when taking Elavil.
Among them, 19 people (0.1%) have Bronchial secretion retention.

Could Elavil cause Bronchial secretion retention?

Among these 19 people:

What is the gender of people who have Bronchial secretion retention when taking Elavil? *

female: 5.26 %
male: 94.74 %

What is the age of people who have Bronchial secretion retention when taking Elavil? *

What are other drugs people take besides Elavil? *

What are other side effects people have besides Bronchial secretion retention? *

Dyspnea (difficult or laboured breathing): 19 people, 100.00%
Weakness: 18 people, 94.74%
Stress And Anxiety: 18 people, 94.74%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 18 people, 94.74%
Headache (pain in head): 18 people, 94.74%
Fever: 18 people, 94.74%
Pneumonia: 18 people, 94.74%
Sepsis (a severe blood infection that can lead to organ failure and death): 18 people, 94.74%
Coughing Up Blood: 18 people, 94.74%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 18 people, 94.74%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 17 people, 89.47%
Swelling: 1 person, 5.26%
Procedural Pain: 1 person, 5.26%
Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and have Bronchial secretion retention?

- Check whether Bronchial secretion retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elavil:

Elavil (20,724 reports)

Browse all side effects of Elavil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchial secretion retention:

Bronchial secretion retention (276 drugs)

Browse all the conditions that are associated with Bronchial secretion retention:

Bronchial secretion retention (309 conditions)

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Elavil) and Elavil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.